XELOX Clinical Trials
12 recruitingDrug
Phase 28Phase 33Phase 12
Showing 1–12 of 12 trials
Recruiting
Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
AstraZeneca163 enrolled44 locationsNCT05702229
Recruiting
Phase 3
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
Gastric CancerMetastatic CancerAdvanced Cancer+1 more
Centre Leon Berard132 enrolled6 locationsNCT06346197
Recruiting
Phase 1
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Colorectal, CancerLiver MetastasisLDRT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University9 enrolled2 locationsNCT06848465
Recruiting
Phase 2
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
Colon Cancer
West China Hospital60 enrolled9 locationsNCT06242418
Recruiting
Phase 1Phase 2
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Zhejiang Cancer Hospital90 enrolled1 locationNCT06650332
Recruiting
Phase 2
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital25 enrolled1 locationNCT06506292
Recruiting
Phase 2
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Harbin Medical University50 enrolled1 locationNCT06196697
Recruiting
Phase 2
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University18 enrolled1 locationNCT06023758
Recruiting
Phase 2
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Advanced Rectal Cancer
Zhen-Hai Lu121 enrolled1 locationNCT05228431
Recruiting
Phase 2
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting
Phase 3
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Cancer of Stomach, Adenocarcinoma
Chinese University of Hong Kong110 enrolled1 locationNCT05264896
Recruiting
Phase 3
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Rectal Cancer
Sun Yat-sen University776 enrolled2 locationsNCT03671252